References
- Imig, J. D., & Hammock, B. D. (2009). Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nature Reviews Drug Discovery, 8(10), 794. doi:10.1038/nrd2875
- Krishna, S., Lakra, A. D., Shukla, N., Khan, S., Mishra, D. P., Ahmed, S., & Siddiqi, M. I. (2019). Identification of potential histone deacetylase1 (HDAC1) inhibitors using multistep virtual screening approach including SVM model, pharmacophore modeling, molecular docking and biological evaluation. Journal of Biomolecular Structure and Dynamics. doi:10.1080/07391102.2019.1654925
- Moser, D., Achenbach, J., Klingler, F. M., Hahn, S., & Proschak, E. (2012). Evaluation of structure-derived pharmacophore of soluble epoxide hydrolase inhibitors by virtual screening. Bioorganic & Medicinal Chemistry Letters, 22(21), 6762–6765. doi:10.1016/j.bmcl.2012.08.066
- Podolin, P. L., Bolognese, B. J., Foley, J. F., Long, E., III, Peck, B., Umbrecht, S., … Quinn, C. (2013). In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor. Prostaglandins & Other Lipid Mediators, 104, 25–31. doi:10.1016/j.prostaglandins.2013.02.001
- Ren, Q., Ma, M., Yang, J., Nonaka, R., Yamaguchi, A., Ishikawa, K-I., … Hashimoto, K. (2018). Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson’s disease. Proceedings of the National Academy of Sciences of the United States of America, 115(25), E5815–E5823. doi:10.1073/pnas.1802179115
- Revermann, M., Barbosa-Sicard, E., Dony, E., Schermuly, R. T., Morisseau, C., Geisslinger, G., … Brandes, R. P. (2009). Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats. Journal of Hypertension, 27(2), 322. doi:10.1097/HJH.0b013e32831aedfa
- Samokhvalov, V., Jamieson, K. L., Darwesh, A. M., Keshavarz-Bahaghighat, H., Lee, T. Y. T., Edin, M., … Seubert, J. M. (2019). Deficiency of soluble epoxygenase protects cardiac function impaired by LPS-induced acute inflammation. Frontiers in Pharmacology, 9, 1572. doi:10.3389/fphar.2018.01572
- Shen, H. C., & Hammock, B. D. (2012). Discovery of inhibitors of soluble epoxide hydrolase: A target with multiple potential therapeutic indications. Journal of Medicinal Chemistry, 55(5), 1789–1808. doi:10.1021/jm201468j
- Shih, P. A. B. (2017). Integrating multi-omics biomarkers and postprandial metabolism to develop personalized treatment for anorexia nervosa. Prostaglandins & Other Lipid Mediators, 132, 69–76. doi:10.1016/j.prostaglandins.2017.02.002
- Tanaka, D., Tsuda, Y., Shiyama, T., Nishimura, T., Chiyo, N., Tominaga, Y., … Kusunose, N. (2011). A practical use of ligand efficiency indices out of the fragment-based approach: Ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors. Journal of Medicinal Chemistry, 54(3), 851–857. doi:10.1021/jm101273e
- Tran, L., Kompa, A. R., Wang, B. H., & Krum, H. (2012). Evaluation of the effects of urotensin II and soluble epoxide hydrolase inhibitor on skin microvessel tone in healthy controls and heart failure patients. Cardiovascular Therapeutics, 30(5), 295–300. doi:10.1111/j.1755-5922.2011.00282.x
- Tripathi, N., Paliwal, S., Sharma, S., Verma, K., Gururani, R., Tiwari, A., … Pant, A. (2018). Discovery of novel soluble epoxide hydrolase inhibitors as potent vasodilators. Scientific Reports, 8(1), 14604. doi:10.1038/s41598-018-32449-4
- Waltenberger, B., Garscha, U., Temml, V., Liers, J., Werz, O., Schuster, D., & Stuppner, H. (2016). Discovery of potent soluble epoxide hydrolase (sEH) inhibitors by pharmacophore-based virtual screening. Journal of Chemical Information and Modeling, 56(4), 747–762. doi:10.1021/acs.jcim.5b00592
- Xing, L., McDonald, J. J., Kolodziej, S. A., Kurumbail, R. G., Williams, J. M., Warren, C. J., … Roberds, S. L. (2011). Discovery of potent inhibitors of soluble epoxide hydrolase by combinatorial library design and structure-based virtual screening. Journal of Medicinal Chemistry, 54(5), 1211–1222. doi:10.1021/jm101382t
- Yang, G. Y. (2018). Proinflammatory enzyme soluble epoxide hydrolase bridges obesity to colonic inflammation and potential carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America, 115(23), 5827–5828. doi:10.1073/pnas.1807520115